by October Gallery
(Reuters Health) – One in eight adults with heart disease delays filling prescriptions. takes less of the medication than prescribed, or skips medications altogether because of high out-of-pocket costs, a…
(Reuters) – The U.S. Food and Drug Administration on Friday approved bit.ly/2pIFzi5 Aquestive Therapeutics’ treatment for neurological disorder amyotrophic lateral sclerosis (ALS). Shares of the company, which developed riluzole oral…
ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved…
WASHINGTON (Reuters) – U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer and epilepsy, despite exemptions in the measures for imports of…
(Reuters) – Johnson & Johnson said on Friday its investigation into asbestos contamination of its baby powder could take 30 days or more, after announcing it planned to recall about…
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood disorder, the company said. The treatment, Ultomiris, has already been…
(Reuters) – OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company’s controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging…
NEW YORK (Reuters) – A CVS Health Corp (CVS.N) health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained…
People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton (Reuters) – CVS Health Corp said on…
WASHINGTON (Reuters) – House Democrats’ plan to help lower the cost of medicines should be a priority for the White House, U.S. House Speaker Nancy Pelosi told reporters on Thursday…